Pause Studio Franchise Cost & Review

Pause Studio is a Los Angeles-born luxury recovery concept: float tanks, contrast suites, cryotherapy, IV infusions, and red light in a heavily designed, premium-priced package. It franchised recently — 100+ territories awarded, first franchise openings in 2024 — which makes it the newest system in our recovery set, newer even than SWTHZ.

Figures below come from Pause's 2025 Franchise Disclosure Document. Brands refile every year; the document the franchisor hands you is the one that governs, not this page. We are not affiliated with, endorsed by, or compensated by Pause Studio. See our disclosure policy.

What it costs

Two things stand out. The build is heavy — a $1,207,750 midpoint, in SWTHZ territory, because floats, contrast suites, and IV bays all demand plumbing, drainage, and moisture engineering (see our cold plunge and sauna buyer's guides for why wet builds cost what they do). And the 1% brand fund is the lowest in our data — most competitors take 2–3% — which makes the ongoing stack lighter than the entry price suggests: roughly 8.9% all-in at $1M of revenue.

What the Item 19 actually shows — and what it can't

Those are genuinely impressive numbers — $1.3M+ per studio would imply capital efficiency above 1.0x even at the top of the investment range. But every one of them is a company-operated flagship in Los Angeles, the single most favorable market in America for premium recovery: dense, wealthy, wellness-saturated, and operated by the founding team itself.

This is the SWTHZ small-sample problem in a sharper form. SWTHZ at least disclosed thirteen franchised units; Pause discloses zero. Company-store economics differ from franchise economics in ways that all point the same direction — no royalty drag, founder-level operations, flagship real estate — so treat the disclosed range as a demonstration of the concept's ceiling, not a baseline for your market. Our table carries no revenue figure for Pause for exactly this reason.

The economics if the model travels — and if it doesn't

Run both cases. If a franchise studio in a strong non-LA market reaches even the bottom of the disclosed range ($1.29M), the math is excellent: ~1.07x capital efficiency at the midpoint build, an ~8.9% fee load, and pricing power the passive-modality concepts lack. If it instead performs like the broader recovery category — SWTHZ's franchised average is $573,762, Restore's $911,516 — a $1.2M build produces 0.5–0.75x efficiency and the ~$115,000 annual fee-and-tech load lands on a much thinner gross.

The honest midpoint: Pause's IV and float lines carry higher tickets than a contrast-only studio, which argues for the upper half of that spread — in markets with LA-like demographics. The concept's transferability to ordinary affluent suburbs is exactly the thing no document yet demonstrates.

Is Pause Studio worth it?

Not yet on evidence — on conviction. The disclosure is candid about what exists (five excellent company stores) and silent on the only question a franchisee needs answered (what a franchised unit earns elsewhere). The first 2024 openings will start answering it; until a future FDD reports franchised cohort data, every buyer is effectively in the pilot group.

Worth it if you are in a genuinely LA-comparable market, capitalized well past the $1M net-worth floor, and get current franchisees — however few — to share real ramp numbers. Not worth it if the loan needs disclosed franchise performance to underwrite, or if your market's premium-wellness depth is a hope rather than a demonstrated fact. Restore remains the disclosed-evidence choice in multi-modality recovery.

Who this fits

Pause fits a well-capitalized buyer in a top-tier metro who wants the most design-forward, premium-positioned entry in the category and accepts pilot-cohort risk in exchange for prime territory in a young system. Hospitality and luxury-services operators will recognize the model's demands.

It fits poorly for secondary markets, thinly capitalized buyers at the minimum requirements, and anyone who reads a $1.5M possible build against zero franchised data points and needs this review to tell them what that means.

Before you sign

Ask the franchisor for month-by-month revenue on every franchised studio open so far — with a system this young they know each one personally, and reluctance to share is itself information. Talk to the earliest franchisees about build cost overruns versus the Item 7 range; wet builds overrun more than most. Confirm your state's IV-therapy supervision rules, work the due diligence checklist, read Item 19 with our guide beside it, and model the SWTHZ-average case — not the LA case — in the ROI and payback calculator.

Sources

• 1851 Franchise — Pause franchise costs, fees, profit and data
• SharpSheets — Pause Studio franchise FDD, profits & costs

Frequently asked questions

How much does a Pause Studio franchise cost?

+

The 2025 FDD discloses a total initial investment of $880,600 to $1,534,900, including a $60,000 initial franchise fee, with a $400,000 liquid capital and $1,000,000 net worth requirement. Veterans receive a $5,000 discount on the first franchise.

How much revenue does a Pause Studio generate?

+

The Item 19 reports only the five company-owned Los Angeles studios, which grossed between $1,285,791 and $1,789,882 in 2024. No franchised locations are in the sample — the first franchise openings came in 2024 — so there is no evidence yet of what the model earns outside company-run LA flagships.

What services does Pause Studio offer?

+

Flotation therapy, contrast therapy (sauna and cold plunge), cryotherapy, IV vitamin infusions, and LED red-light therapy in a design-forward, premium-priced studio format.

What are Pause Studio's ongoing fees?

+

A 7% royalty and a 1% marketing fund on gross revenue — the lowest brand-fund rate among the brands we compare — plus an $800 monthly technology fee. At $1 million of revenue the combined load is roughly 8.9% of gross; at $500,000 it is about 9.9%, since the flat technology fee weighs more as revenue falls.